# Study to Assess the Effect of BMS-790052 on the Pharmacokinetics of Ortho Tri-Cyclen® in Healthy Female Subjects

> **NCT00983957** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 47 (actual)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **DRUG:** BMS-790052
- **DRUG:** Ortho Tri-Cyclen®

## Key facts

- **NCT ID:** NCT00983957
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2015-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00983957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00983957, "Study to Assess the Effect of BMS-790052 on the Pharmacokinetics of Ortho Tri-Cyclen® in Healthy Female Subjects". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT00983957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*